Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.56+0.08 (+5.41%)
Close on Nov 17, 2026Market cap $878.81KP/E –Yield –
Universe Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Universe Pharmaceuticals's pe ratio was 3.0× on Nov 30, 2022, against 4.6× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Nov 30, 2022 | 3.0× | +0.3 |
| 2021 | Dec 31, 2021 | 2.7× | – |
See a number that looks wrong?